Affiliations 

  • 1 Institute of Biomedical Sciences, College of Health Sciences, Mekelle University, Ethiopia; Department of Biotechnology, Faculty of Science and Humanities, SRM University, Kattankulathur, 603203, India
  • 2 Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Malaysia. Electronic address: yele.gopi@gmail.com
  • 3 Department of Biotechnology, Faculty of Science and Humanities, SRM University, Kattankulathur, 603203, India
  • 4 Department of Botany and Microbiology, College of Science, King Saud University, P.O. 2455, Riyadh 11451, Saudi Arabia
  • 5 Department of Genetic Engineering and SRM Research Institue, SRM University, Kattankulathur, 603203, India
Microb Pathog, 2018 Feb;115:57-63.
PMID: 29248514 DOI: 10.1016/j.micpath.2017.12.039

Abstract

Zinc oxide nanoparticles (ZnONPs) exhibit abundant biomedical applications. Anisotropic ZnONPs with a defined shape and size were synthesized using Bacillus megaterium (NCIM 2326) cell free extract as a bio-reductant. The study investigated the multidimensional effect of ZnONPs on Helicobacter pylori strains and assessed its biosafety in normal human mesenchymal stem cells (hMSc). The highly stable ZnONPs were produced using B. megaterium and Zinc nitrate as a precursor. The phase of ZnONPs formation and structural characterization were performed by UV- visible (UV-Vis), Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD) and Field Emission Scanning electron microscopy (FESEM) analysis. Furthermore, the ZnONPs exhibited higher biocompatibility against human mesenchymal stem cells (hMSC) and proved to be potentially safe in mammalian cells. Corroborating the current investigation, we described the anti-H. Pylori dosage of ZnONPs was safe to hMSC and could efficiently use as nano-antibiotic.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.